Dr. Fazio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3303 S Bond Ave
Portland, OR 97239Phone+1 503-418-9008
Education & Training
- Sapienza University of RomeClass of 1983
Certifications & Licensure
- OR State Medical License 2016 - 2020
- TN State Medical License 1994 - 2014
Awards, Honors, & Recognition
- Board of Directors American Board of Clinical Lipidology, 2015
- Elected Member Association of American Physicians, 2011
- Elected Member American Society for Clinical Investigation, 2001
Publications & Presentations
PubMed
- 13 citationsRace-Dependent Association of High-Density Lipoprotein Cholesterol Levels With Incident Coronary Artery Disease.Neil A Zakai, Jessica Minnier, Monika M Safford, Insu Koh, Marguerite R Irvin
Journal of the American College of Cardiology. 2022-11-29 - 17 citationsReal-world utilization of bempedoic acid in an academic preventive cardiology practice.Bruce A Warden, Bcps-Aq Cardiology, Jonathan Q Purnell, P Barton Duell, Sergio Fazio
Journal of Clinical Lipidology. 2021-12-04 - 9 citationsMacrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis.Paul Mueller, Yoko Kojima, Katherine T. Huynh, Richard A Maldonado, Jianqin Ye
Arteriosclerosis, Thrombosis, and Vascular Biology. 2021-11-11
Journal Articles
- The Present and Future JACC State-of-the-Art Review the Evolving Future of PCSK9 InhibitorsRobert S Rosenson, Sergio Fazio, ScienceDirect
- Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL CholesterolSephy Philip, Sergio Fazio, The Journal of Clinical Endocrinology and Metabolism
- Effects of 12 Weeks of Treatment with Intravenously Administered Bococizumab, a Humanized Monoclonal Antibody Blocking Proprotein Convertase subtilisin/kexin Type 9, i...Charles M Baum, Sergio Fazio, Cardiovascular Therapeutics
Lectures
- Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 InhibitorENDO 2019 - New Orleans, LA - 3/25/2019
- Cholesterol-Carrying Lipoproteins and Cardiovascular Risk: New Guidelines and BeyondENDO 2019 - New Orleans, LA - 3/24/2019
- Familial Lipid Disorders: What Every Lipid-Savvy Endocrinologist Needs to KnowENDO 2019 - New Orleans, LA - 3/23/2019
- Join now to see all
Press Mentions
- Erin Michos, MD, MHS, FASPC Is Named Co Editor-in-Chief of the American Journal of Preventive CardiologyFebruary 17th, 2021
- AACE/ACE Consensus Statement Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive SummaryDecember 28th, 2020
- ASPC Launches New Journal Focused on Preventive CardiologyMarch 27th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: